CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,030,805
- in 10 filings, $173K under 10b5-1 plans
Net −$1,030,805. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Hughes Douglas J. Director | Grant or award · Stock Option (right to buy) | +7,600 | 7,600 | ||
| 2025-04-01 | Fromkin Andrew J. Director | Grant or award | +16,188 | 108,101 | ||
| 2025-04-01 | Fromkin Andrew J. Director | Grant or award · Stock Option (right to buy) | +7,600 | 7,600 | ||
| 2025-04-01 | MIGAUSKY GEORGE V Director | Grant or award | +16,188 | 137,251 | ||
| 2025-04-01 | MIGAUSKY GEORGE V Director | Grant or award · Stock Option (right to buy) | +7,600 | 7,600 | ||
| 2025-04-01 | Torti Frank Director | Grant or award | +199,365 | 835,039 | ||
| 2025-04-01 | Torti Frank Director | Grant or award · Stock Option (right to buy) | +93,599 | 93,599 | ||
| 2025-03-07 | Fromkin Andrew J. Director | Sale 10b5-1 | −6,616 | $19.52 | $129K | 93,297 |
| 2025-03-07 | Fromkin Andrew J. Director | Sale 10b5-1 | −1,384 | $19.96 | $28K | 91,913 |
| 2025-02-19 | Macias William L. Chief Medical Officer | Sale | −2,055 | $20.86 | $43K | 357,353 |
| 2025-02-19 | Barnett Eva Renee Chief Financial Officer | Sale | −2,814 | $20.86 | $59K | 321,952 |
| 2025-02-19 | Salzmann Peter Chief Executive Officer | Sale | −15,439 | $20.86 | $322K | 948,786 |
| 2025-01-22 | Stout Jay S Chief Technology Officer | Sale | −2,195 | $23.59 | $52K | 139,991 |
| 2025-01-22 | Geffner Michael Chief Medical Officer | Sale | −2,657 | $23.59 | $63K | 132,314 |
| 2025-01-15 | Macias William L. Chief Medical Officer | Sale | −1,883 | $23.81 | $45K | 359,908 |
| 2025-01-15 | Macias William L. Chief Medical Officer | Sale | −94 | $24.19 | $2K | 359,814 |
| 2025-01-15 | Macias William L. Chief Medical Officer | Sale | −387 | $23.81 | $9K | 359,427 |
| 2025-01-15 | Macias William L. Chief Medical Officer | Sale | −19 | $24.19 | $460 | 359,408 |
| 2025-01-15 | Barnett Eva Renee Chief Financial Officer | Sale | −2,189 | $23.81 | $52K | 324,875 |
| 2025-01-15 | Barnett Eva Renee Chief Financial Officer | Sale | −109 | $24.19 | $3K | 324,766 |
Page 9 of 10 · 191 trades